Zika virus infection medical therapy

Revision as of 19:32, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Zika virus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Zika Virus Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Evaluation of Pregnant Women

Evaluation of Infants

Collection and Submission of Fetal Tissues

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Guidelines for Pregnant Women
Travel Notice
Blood Donation
Sexual transmission

Secondary Prevention

CDC Response Planning Tips

Risk-based Preparedness for States

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zika virus infection medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zika virus infection medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zika virus infection medical therapy

CDC on Zika virus infection medical therapy

Zika virus infection medical therapy in the news

Blogs on Zika virus infection medical therapy

Directions to Hospitals Treating Zika virus infection

Risk calculators and risk factors for Zika virus infection medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D., Nate Michalak, B.A., Serge Korjian M.D.

Overview

The mainstay of therapy for Zika virus infection is supportive care. Supportive care includes includes rest, adequate fluids intake, and administration of antipyretics and analgesics. Aspirin and other NSAIDs should be avoided until Dengue fever is ruled out, as NSAIDs may increase the risk of hemorrhage in patients with Dengue fever. Antiviral treatment is not recommended for the management of Zika virus infection. The general principles of medical therapy for the management of Zika virus apply to pregnant women. Treatment of congenital Zika virus infection is supportive and should address specific medical and neurodevelopmental issues for the infant’s particular needs. Mothers are encouraged to breastfeed infants even in areas where Zika virus is found, as available evidence indicates the benefits of breastfeeding outweigh any theoretical risks associated with Zika virus infection transmission through breast milk.[1][2]

Medical Therapy

  • The mainstay of therapy for Zika virus infection is supportive care:
  • Rest
  • Adequate fluid intake
  • Pharmacologic therapy (i.e., antipyretic agents and/or analgesics)
  • Antiviral treatment is not recommended for the management of Zika virus infection.
  • There is no vaccine or medicine for Zika virus infection.[3]

Special Considerations

Management of Pregnant Women

  • The general principles of medical therapy for the management of Zika virus apply to pregnant women (i.e., rest, fluids, acetaminophen antipyretic therapy if needed, avoid aspirin and NSAIDS).
  • In a pregnant woman with laboratory evidence of Zika virus in serum or amniotic fluid, serial ultrasounds should be considered to monitor fetal anatomy and growth every 3–4 weeks.
  • Referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended.

Management of Congenital Zika Virus Infection

  • No specific antiviral treatment is available for Zika virus infections.
  • Treatment of congenital Zika virus infection is supportive and should address specific medical and neurodevelopmental issues for the infant’s particular needs; investigations are ongoing to better understand what services will be most effective for these children as they grow.
  • Mothers are encouraged to breastfeed infants even in areas where Zika virus is found, as available evidence indicates the benefits of breastfeeding outweigh any theoretical risks associated with Zika virus infection transmission through breast milk.[1][2]
  • Developmental monitoring and screening during the first year of life is recommended for all children with congenital Zika virus infection.

References

  1. 1.0 1.1 Besnard M, Lastere S, Teissier A, Cao-Lormeau V, Musso D (2014). "Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014". Euro Surveill. 19 (13). PMID 24721538.
  2. 2.0 2.1 Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ; et al. (2005). "Breastfeeding and the use of human milk". Pediatrics. 115 (2): 496–506. doi:10.1542/peds.2004-2491. PMID 15687461.
  3. 3.0 3.1 Zika virus. Center for Disease Control and Prevention for Medical Professionals. http://www.cdc.gov/zika/hc-providers/clinicalevaluation.html Accessed on December 14, 2015